Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC4R | P32245 | 10/20 | 0.49 |
| ▸ | MC5R | P33032 | 10/20 | 0.49 |
| ▸ | MC3R | P41968 | 10/20 | 0.49 |
| ▸ | MC1R | Q01726 | 10/20 | 0.49 |
| ▸ | PIN1 | Q13526 | 2/20 | 0.45 |
| ▸ | ITGB3 | P05106 | 6/20 | 0.44 |
| ▸ | ITGAV | P06756 | 4/20 | 0.44 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.44 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.44 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.43 |
| ▸ | ITGB5 | P18084 | 1/20 | 0.43 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.43 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10000329 | 0.93 | CACNA1B (0.49) | MC4RMC5RMC3RMC1RPIN1 | |
| SCHEMBL24975502 | 0.93 | PIN1 (0.49) | MC4RMC5RMC3RMC1RPIN1 | |
| SCHEMBL15853554 | 0.92 | MC4R (0.46) | MC4RMC5RMC3RMC1RPIN1 | |
| SCHEMBL12146076 | 0.92 | ITGB3 (0.50) | MC4RMC5RMC3RMC1RPIN1 | |
| SCHEMBL22872754 | 0.90 | ITGB3 (0.49) | MC4RMC5RMC3RMC1RPIN1 | |
| SCHEMBL25474210 | 0.88 | MC4R (0.55) | MC4RMC5RMC3RMC1RITGB3 | |
| SCHEMBL19605464 | 0.88 | MC4R (0.55) | MC4RMC5RMC3RMC1RITGB3 | |
| SCHEMBL10259650 | 0.87 | MC4R (0.62) | MC4RMC5RMC3RMC1RITGB3 | |
| SCHEMBL29666716 | 0.86 | PIN1 (0.46) | MC4RMC5RMC3RMC1RPIN1 | |
| SCHEMBL29569086 | 0.86 | ITGB3 (0.49) | MC4RMC5RMC3RMC1RITGB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9775803-B2 | Liposome comprising elastin-like polypeptide and tumor cell targeting material and use thereof | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-10-03 | — | — | US | disclosed |
| US-20170165198-A9 | LIPOSOME COMPRISING ELASTIN-LIKE POLYPEPTIDE AND TUMOR CELL TARGETING MATERIAL AND USE THEREOF | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-06-15 | — | — | US | disclosed |
| US-20130102993-A1 | LIPOSOME COMPRISING ELASTIN-LIKE POLYPEPTIDE AND TUMOR CELL TARGETING MATERIAL AND USE THEREOF | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2013-04-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130102993-A1 | LIPOSOME COMPRISING ELASTIN-LIKE POLYPEPTIDE AND TUMOR CELL TARGETING MATERIAL AND USE THEREOF | LNPEP, EBPL, LIPG | MC4R 2977/4885MC5R 4145/4885MC3R 3546/4885 |
| US-20170165198-A9 | LIPOSOME COMPRISING ELASTIN-LIKE POLYPEPTIDE AND TUMOR CELL TARGETING MATERIAL AND USE THEREOF | LNPEP, EBPL, LIPG | MC4R 2977/4885MC5R 4145/4885MC3R 3546/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.